Selective RNA pseudouridinylation in situ by circular gRNAs in designer organelles.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 28 10 2023
accepted: 11 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

RNA modifications play a pivotal role in the regulation of RNA chemistry within cells. Several technologies have been developed with the goal of using RNA modifications to regulate cellular biochemistry selectively, but achieving selective and precise modifications remains a challenge. Here, we show that by using designer organelles, we can modify mRNA with pseudouridine in a highly selective and guide-RNA-dependent manner. We use designer organelles inspired by concepts of phase separation, a central tenet in developing artificial membraneless organelles in living mammalian cells. In addition, we use circular guide RNAs to markedly enhance the effectiveness of targeted pseudouridinylation. Our studies introduce spatial engineering through optimized RNA editing organelles (OREO) as a complementary tool for targeted RNA modification, providing new avenues to enhance RNA modification specificity.

Identifiants

pubmed: 39448590
doi: 10.1038/s41467-024-53403-1
pii: 10.1038/s41467-024-53403-1
doi:

Substances chimiques

Pseudouridine 1445-07-4
RNA, Guide, CRISPR-Cas Systems 0
RNA, Messenger 0
RNA, Circular 0
RNA 63231-63-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9177

Informations de copyright

© 2024. The Author(s).

Références

Delaunay, S., Helm, M. & Frye, M. RNA modifications in physiology and disease: towards clinical applications. Nat. Rev. Genet. 25,104–122 (2023).
Kierzek, E. et al. The contribution of pseudouridine to stabilities and structure of RNAs. Nucleic Acids Res. 42, 3492–3501 (2014).
doi: 10.1093/nar/gkt1330 pubmed: 24369424
Cerneckis, J., Cui, Q., He, C., Yi, C. & Shi, Y. Decoding pseudouridine: an emerging target for therapeutic development. Trends Pharmacol. Sci. 43, 522–535 (2022).
doi: 10.1016/j.tips.2022.03.008 pubmed: 35461717
Anderson, B. R. et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884–5892 (2010).
doi: 10.1093/nar/gkq347 pubmed: 20457754 pmcid: 2943593
Karijolich, J. & Yu, Y.-T. Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474, 395–398 (2011).
doi: 10.1038/nature10165 pubmed: 21677757 pmcid: 3381908
De Boeck, K., Zolin, A., Cuppens, H., Olesen, H. V. & Viviani, L. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J. Cyst. Fibros. 13, 403–409 (2014).
doi: 10.1016/j.jcf.2013.12.003 pubmed: 24440181
Adachi, H. et al. Targeted pseudouridylation: an approach for suppressing nonsense mutations in disease genes. Mol. Cell 83, 637–651.e9 (2023).
doi: 10.1016/j.molcel.2023.01.009 pubmed: 36764303 pmcid: 9975048
Song, J. et al. CRISPR-free, programmable RNA pseudouridylation to suppress premature termination codons. Mol. Cell 83, 139–155.e9 (2023).
doi: 10.1016/j.molcel.2022.11.011 pubmed: 36521489
Rintala-Dempsey, A. C. & Kothe, U. Eukaryotic stand-alone pseudouridine synthases—RNA modifying enzymes and emerging regulators of gene expression? RNA Biol. 14, 1185–1196 (2017).
doi: 10.1080/15476286.2016.1276150 pubmed: 28045575 pmcid: 5699540
Garus, A. & Autexier, C. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance. RNA 27, 1441–1458 (2021).
doi: 10.1261/rna.078953.121 pubmed: 34556550 pmcid: 8594475
Reinkemeier, C. D., Girona, G. E. & Lemke, E. A. Designer membraneless organelles enable codon reassignment of selected mRNAs in eukaryotes. Science 363, eaaw2644 (2019).
doi: 10.1126/science.aaw2644 pubmed: 30923194 pmcid: 7611745
Reinkemeier, C. D. & Lemke, E. A. Dual film-like organelles enable spatial separation of orthogonal eukaryotic translation. Cell 184, 4886–4903.e21 (2021).
doi: 10.1016/j.cell.2021.08.001 pubmed: 34433013 pmcid: 8480389
Adachi, H. et al. Targeted pseudouridylation: a novel approach for suppressing nonsense mutations in disease genes. Mol. Cell. 83, 637–651.e9 (2021).
Litke, J. L. & Jaffrey, S. R. Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. Nat. Biotechnol. 37, 667–675 (2019).
doi: 10.1038/s41587-019-0090-6 pubmed: 30962542 pmcid: 6554452
Yi, Z. et al. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat. Biotechnol. 40, 946–955 (2022).
doi: 10.1038/s41587-021-01180-3 pubmed: 35145313
Katrekar, D. et al. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat. Biotechnol. 40, 938–945 (2022).
doi: 10.1038/s41587-021-01171-4 pubmed: 35145312 pmcid: 9232839
Ngo, L. H. et al. Nuclear export of circular RNA. Nature 627, 212–220 (2024).
doi: 10.1038/s41586-024-07060-5 pubmed: 38355801
Daigle, N. & Ellenberg, J. N-GFP: an RNA reporter system for live-cell imaging. Nat. Methods 4, 633–636 (2007).
doi: 10.1038/nmeth1065 pubmed: 17603490
Jain, M., Abu-Shumays, R., Olsen, H. E. & Akeson, M. Advances in nanopore direct RNA sequencing. Nat. Methods 19, 1160–1164 (2022).
doi: 10.1038/s41592-022-01633-w pubmed: 36203024 pmcid: 11388133
Leger, A. et al. RNA modifications detection by comparative Nanopore direct RNA sequencing. Nat. Commun. 12, 7198 (2021).
doi: 10.1038/s41467-021-27393-3 pubmed: 34893601 pmcid: 8664944
Furlan, M. et al. Computational methods for RNA modification detection from nanopore direct RNA sequencing data. RNA Biol. 18, 31–40 (2021).
doi: 10.1080/15476286.2021.1978215 pubmed: 34559589 pmcid: 8677041
Begik, O. et al. Quantitative profiling of pseudouridylation dynamics in native RNAs with nanopore sequencing. Nat. Biotechnol. 39, 1278–1291 (2021).
doi: 10.1038/s41587-021-00915-6 pubmed: 33986546
Tavakoli, S. et al. Semi-quantitative detection of pseudouridine modifications and type I/II hypermodifications in human mRNAs using direct long-read sequencing. Nat. Commun. 14, 334 (2023).
doi: 10.1038/s41467-023-35858-w pubmed: 36658122 pmcid: 9852470
Martins-Dias, P. & Romão, L. Nonsense suppression therapies in human genetic diseases. Cell. Mol. Life Sci. 78, 4677–4701 (2021).
doi: 10.1007/s00018-021-03809-7 pubmed: 33751142 pmcid: 11073055
Jülicher, F. & Weber, C. A. Droplet physics and intracellular phase separation. Annu. Rev. Condens. Matter Phys. 15, 237–261 (2024).
doi: 10.1146/annurev-conmatphys-031720-032917
Zhao, X., Bartolucci, G., Honigmann, A., Jülicher, F. & Weber, C. A. Thermodynamics of wetting, prewetting and surface phase transitions with surface binding. N. J. Phys. 23, 123003 (2021).
doi: 10.1088/1367-2630/ac320b
Cox, D. B. T. et al. RNA editing with CRISPR-Cas13. Science 358, 1019–1027 (2017).
doi: 10.1126/science.aaq0180 pubmed: 29070703 pmcid: 5793859
Merkle, T. et al. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat. Biotechnol. 37, 133–138 (2019).
doi: 10.1038/s41587-019-0013-6 pubmed: 30692694
Dai, Q. et al. Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution. Nat. Biotechnol. 41, 344–354 (2023).
doi: 10.1038/s41587-022-01505-w pubmed: 36302989
Zhang, L.-S. et al. BID-seq for transcriptome-wide quantitative sequencing of mRNA pseudouridine at base resolution. Nat. Protoc. 19, 517–538 (2024).
doi: 10.1038/s41596-023-00917-5 pubmed: 37968414
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
doi: 10.1093/bioinformatics/btu170 pubmed: 24695404 pmcid: 4103590
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
doi: 10.1038/nmeth.1923 pubmed: 22388286 pmcid: 3322381
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
doi: 10.1093/bioinformatics/bty191 pubmed: 29750242 pmcid: 6137996
De Coster, W. & Rademakers, R. NanoPack2: population-scale evaluation of long-read sequencing data. Bioinformatics 39, btad311 (2023).
doi: 10.1093/bioinformatics/btad311 pubmed: 37171891 pmcid: 10196664
Waskom, M. Seaborn: statistical data visualization. JOSS 6, 3021 (2021).
doi: 10.21105/joss.03021
Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90–95 (2007).
doi: 10.1109/MCSE.2007.55
Wickham, H. Ggplot2 2nd edn, (Springer International Publishing Cham, 2016).

Auteurs

Lukas Schartel (L)

Biocenter, Johannes Gutenberg University, Mainz, Germany.
Departments of Biology and Chemistry, IMPRS on Cellular Biophysics, Mainz, Germany.

Cosimo Jann (C)

Biocenter, Johannes Gutenberg University, Mainz, Germany.
Institute of Molecular Biology (IMB) Postdoc Programme, Mainz, Germany.

Anna Wierczeiko (A)

Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Tamer Butto (T)

Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, Germany.

Stefan Mündnich (S)

Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, Germany.

Virginie Marchand (V)

Université de Lorraine CNRS, INSERM, UAR2008/US40 IBSLor, EpiRNA-Seq Core Facility, Nancy, France.

Yuri Motorin (Y)

Université de Lorraine CNRS, UMR7365 IMoPA, Nancy, France.

Mark Helm (M)

Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, Germany.

Susanne Gerber (S)

Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Edward A Lemke (EA)

Biocenter, Johannes Gutenberg University, Mainz, Germany. edlemke@uni-mainz.de.
Institute of Molecular Biology, Mainz, Germany. edlemke@uni-mainz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH